NCT05155215 2021-12-13Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell LymphomaBeijing Immunochina Medical Science & Technology Co., Ltd.Phase 1/2 Unknown68 enrolled